Ther Adv Med Oncol

Ther Adv Med Oncol

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

502

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 502 Papers
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis.

Petrelli F, Antista M, Marra F, Cribiu' FM, Rampulla V, Pietrantonio F, Dottorini L, Ghidini M, Luc…

2024 PMID: 38435432
3/7
COI Funding
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC …

Sepe P, Procopio G, Pircher CC, Basso U, Caffo O, Cappelletti V, Claps M, De Giorgi U, Fratino L, G…

2024 PMID: 38264520
4/7
COI Funding
A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patient…

Yu N, Huang S, Zhang Z, Huang M, Wang Y, Zhang W, Zhang X, Zhu X, Sheng X, Yu K, Chen Z, Guo W.

2024 PMID: 38425987
4/7
COI Funding
3/7
COI Funding
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.

Ogata T, Narita Y, Oze I, Kumanishi R, Nakazawa T, Matsubara Y, Kodama H, Nakata A, Honda K, Masuis…

2024 PMID: 38344409
3/7
COI Funding
Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I-IV colorectal canc…

Fan W, Xia Z, Chen R, Lin D, Li F, Zheng Y, Luo J, Xiong Y, Yu P, Gao W, Gong Y, Zhang F, Zhang S, …

2024 PMID: 38282662
3/7
COI Funding
Clinical and molecular characteristics of <i>RNF43</i> mutations as promising prognostic biomarkers in colorectal cance…

Huang ZY, Wen L, Ye LF, Lu YT, Pat Fong W, Zhang RJ, Wu SX, Chen ZG, Cai YY, Xu RH, Li YH, Du ZM, W…

2024 PMID: 38205077
3/7
COI Funding
Current evidence of PD-1 and PD-L1 immune checkpoint inhibitors for esophageal cancer: an updated meta-analysis and syn…

Zafar S, Shehzadi R, Dawood H, Maqbool M, Sarfraz A, Sarfraz Z.

2024 PMID: 38205080
4/7
COI Funding
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.

Tung PH, Chiu TH, Huang AC, Ju JS, Huang CH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo…

2024 PMID: 38249338
3/7
COI Funding
Distinct clinical characteristics in stage III rectal cancer among different age groups and treatment outcomes after ne…

Liu B, Luo H, Li B, Yu H, Sun R, Li J, Gao Y, Ding P, Wang X, Xiao W, Xiao W.

2024 PMID: 38347922
3/7
COI Funding